These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 19789302

  • 1. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis.
    Burden RE, Gormley JA, Jaquin TJ, Small DM, Quinn DJ, Hegarty SM, Ward C, Walker B, Johnston JA, Olwill SA, Scott CJ.
    Clin Cancer Res; 2009 Oct 01; 15(19):6042-51. PubMed ID: 19789302
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas.
    Burden RE, Gormley JA, Kuehn D, Ward C, Kwok HF, Gazdoiu M, McClurg A, Jaquin TJ, Johnston JA, Scott CJ, Olwill SA.
    Biochimie; 2012 Feb 01; 94(2):487-93. PubMed ID: 21896304
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K, Dahlem C, Menger MD, Schilling MK, Kollmar O.
    Ann Surg Oncol; 2009 Sep 01; 16(9):2629-37. PubMed ID: 19551445
    [Abstract] [Full Text] [Related]

  • 4. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
    Mousa SA, Mohamed S, Wexler EJ, Kerr JS.
    Anticancer Res; 2005 Sep 01; 25(1A):197-206. PubMed ID: 15816539
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS.
    Cancer Res; 2004 Jun 15; 64(12):4069-77. PubMed ID: 15205313
    [Abstract] [Full Text] [Related]

  • 6. Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.
    Bentzien F, Struman I, Martini JF, Martial J, Weiner R.
    Cancer Res; 2001 Oct 01; 61(19):7356-62. PubMed ID: 11585777
    [Abstract] [Full Text] [Related]

  • 7. Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF.
    Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, Gazdoiu M, Small D, Bicknell R, Johnston JA, Scott CJ, Olwill SA.
    PLoS One; 2010 Sep 02; 5(9):. PubMed ID: 20824056
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y, Li R, Yamamoto H, Min Y, Piao W, Wang Y, Imsumran A, Li H, Arimura Y, Lee CT, Imai K, Carbone DP, Shinomura Y.
    Carcinogenesis; 2009 Aug 02; 30(8):1305-13. PubMed ID: 19493905
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis.
    Li W, Ding F, Zhang L, Liu Z, Wu Y, Luo A, Wu M, Wang M, Zhan Q, Liu Z.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8753-62. PubMed ID: 16361563
    [Abstract] [Full Text] [Related]

  • 10. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD, Hu Y, Zhang L, Huang J, Sun CY.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 15; 28(10):659-63. PubMed ID: 18399169
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.
    Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE.
    Clin Cancer Res; 2005 Feb 15; 11(4):1551-62. PubMed ID: 15746060
    [Abstract] [Full Text] [Related]

  • 12. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
    Rofstad EK, Mathiesen B, Kindem K, Galappathi K.
    Cancer Res; 2006 Jul 01; 66(13):6699-707. PubMed ID: 16818644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.
    Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA.
    Cancer Cell; 2006 Mar 01; 9(3):225-38. PubMed ID: 16530706
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
    Huang J, Che MI, Huang YT, Shyu MK, Huang YM, Wu YM, Lin WC, Huang PH, Liang JT, Lee PH, Huang MC.
    Carcinogenesis; 2009 Aug 01; 30(8):1452-8. PubMed ID: 19520792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the antiangiogenic potential of AQ4N.
    O'Rourke M, Ward C, Worthington J, McKenna J, Valentine A, Robson T, Hirst DG, McKeown SR.
    Clin Cancer Res; 2008 Mar 01; 14(5):1502-9. PubMed ID: 18316575
    [Abstract] [Full Text] [Related]

  • 20. A new anticancer glycolipid monoclonal antibody, SC104, which directly induces tumor cell apoptosis.
    Durrant LG, Harding SJ, Green NH, Buckberry LD, Parsons T.
    Cancer Res; 2006 Jun 01; 66(11):5901-9. PubMed ID: 16740730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.